Gregory N. Dietsch

Chemokine expression in murine experimental allergic encephalomyelitis

Ronald Godiska, David Chantry, Gregory N. Dietsch et al. · Journal of Neuroimmunology · 1995 · 356 citations

Life Sciences, Immunology, Pathobiology +12

VTX-2337 Is a Novel TLR8 Agonist That Activates NK Cells and Augments ADCC

Hailing Lu, Gregory N. Dietsch, Maura-Ann H. Matthews et al. · Clinical Cancer Research · 2011 · 174 citations

Life Sciences, Immunology, Pharmacology +17

The Role of Recombinant Platelet-Activating Factor Acetylhydrolase in a Neonatal Rat Model of Necrotizing Enterocolitis

Michael S. Caplan, Matthew Lickerman, Luba Adler et al. · Pediatric Research · 1997 · 130 citations

Medicine, Biochemistry, Pathobiology +14

Phase Ib Trial of the Toll-like Receptor 8 Agonist, Motolimod (VTX-2337), Combined with Cetuximab in Patients with Recurrent or Metastatic SCCHN

Laura Q.M. Chow, Chihiro Morishima, Keith D. Eaton et al. · Clinical Cancer Research · 2016 · 126 citations

Medicine, Oncology, Pharmacology +17

Effect of Adding Motolimod to Standard Combination Chemotherapy and Cetuximab Treatment of Patients With Squamous Cell Carcinoma of the Head and Neck

Robert L. Ferris, Nabil F. Saba, Barbara J. Gitlitz et al. · JAMA Oncology · 2018 · 111 citations · Full text

Medicine, Oncology, Pharmacotherapy +13